Corneal Neovascularization: A Combined Approach of Bevacizumab and Suramin Showed Increased Antiangiogenic Effect Through Downregulation of BFGF and P2X2-Reference-Cited by-同舟云学术

Corneal Neovascularization: A Combined Approach of Bevacizumab and Suramin Showed Increased Antiangiogenic Effect Through Downregulation of BFGF and P2X2

Published:2017-12-21 Issue:4 Volume:43 Page:466-473
ISSN:0271-3683
Container-title:Current Eye Research
language:en
Short-container-title:Current Eye Research

Author:

Lopez Emiliano S.¹,Ortiz Gustavo A.¹,Potilinski Constanza¹,Croxatto J. Oscar²^ORCID,Gallo Juan E.¹^ORCID

Affiliation:

1. Nanomedicine & VisionGroup; Instituto de Investigaciones en Medicina Traslacional (IIMT), Universidad Austral-CONICET, Buenos Aires, Argentina

2. Departamento de Patología Ocular, Fundación Oftalmológica Argentina “Jorge Malbran”, Buenos Aires, Argentina

Funder

Universidad Austral

Publisher

Informa UK Limited

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02713683.2017.1416146

Reference33 articles.

1. Corneal neovascularization

2. Efficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysis

3. Change in Diabetic Retinopathy Through 2 Years

4. Subconjunctival bevacizumab for corneal neovascularization

5. Emerging techniques to treat corneal neovascularisation

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of corneal neovascularization by topical application of nintedanib in rabbit models;International Journal of Ophthalmology;2021-11-18

2. Inhibiting corneal neovascularization by sustainably releasing anti-VEGF and anti-inflammation drugs from silica-thermogel nanohybrids;Materials Science and Engineering: C;2021-09

3. Anti-VEGF Treatment in Corneal Diseases;Current Drug Targets;2020-09-18

4. In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization;Experimental Eye Research;2019-08

5. In vitro characterization of new stabilizing albumin nanoparticles as a potential topical drug delivery system in the treatment of corneal neovascularization (CNV);Journal of Drug Delivery Science and Technology;2019-08